RaySearch Laboratories AB (publ) (FRA:27R)

Market Cap	705.82M
Revenue (ttm)	116.82M
Net Income (ttm)	19.83M
Shares Out	n/a
EPS (ttm)	0.58
PE Ratio	35.60
Forward PE	30.15
Dividend	0.28 (1.35%)
Ex-Dividend Date	May 23, 2025

Volume	n/a
Average Volume	5
Open	21.05
Previous Close	20.85
Day's Range	21.05 - 21.05
52-Week Range	17.20 - 32.70
Beta	n/a
RSI	52.64
Earnings Date	Nov 7, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation...

• Industry: Prepackaged Software
• Founded: 2000
• Employees: 416
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 27R

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK